Primary leptomeningeal melanomatosis successfully treated with PD-1 inhibitor pembrolizumab
Sign Up to like & getrecommendations! Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000022928
Abstract: Abstract Rationale: Primary leptomeningeal melanoma is an extremely rare disease of the central nervous system. There are no standard treatment protocols with a poor prognosis in very few reported cases. Immunotherapy in primary brain melanoma… read more here.
Keywords: successfully treated; leptomeningeal melanomatosis; inhibitor pembrolizumab; primary leptomeningeal ... See more keywords
PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy
Sign Up to like & getrecommendations! Published in 2021 at "Therapeutic Advances in Neurological Disorders"
DOI: 10.1177/1756286421993684
Abstract: The reactivation of human JC polyoma virus (JCPyV) results in lytic infection of oligodendrocytes and neuronal cells. The corresponding clinical picture is called progressive multifocal leukoencephalopathy (PML) and results mostly from a disease-related or drug-induced… read more here.
Keywords: inhibitor pembrolizumab; treatment; progressive multifocal; multifocal leukoencephalopathy ... See more keywords